As of February 24, 2025, the FDA no longer expects prescribers, patients and pharmacists to participate in the risk evaluation and mitigation strategies (REMS) program for clozapine. This means pharmacies can dispense clozapine without knowledge of the patients...
The safety and efficacy of traditional antidepressants, antipsychotics, and mood stabilizers (such as lithium andsome anticonvulsants) and stimulant medications have been established through decades of rigorous research,randomized clinical trials, peer-reviewed...
The American Society for Clinical Psychopharmacology (ASCP) has learned with significant concern about the National Institutes of Health (NIH) plan, shared on February 7 and scheduled to become effective on February 10, to limit the indirect cost rate for biomedical...
CALL FOR PAPERSThe Journal of Clinical Psychiatry, official journal of the ASCP, wants your article submissions! What kind of papers is JCP looking for?Systematic reviews and meta-analyses focusing on current, clinically relevant topics in psychiatryNovel methods...
The ASCP is proud to provide the official diversity statement of the society. ASCP Diversity Statement The organization has a commitment to actively promote and welcome diversity and inclusion within the society and within our field. Diversity includes but...
The American Journal of Psychiatry Residents’ Journal featured an article focusing on the purpose, mission, and efforts of the ASCP Model Curriculum. Click here for the full article.
